TipRanks
Orchid Pharma Limited (IN:ORCHPHARMA)
:ORCHPHARMA
India Market
ORCHPHARMA
Orchid Pharma Limited
RESEARCH TOOLSreports
Want to see IN:ORCHPHARMA full AI Analyst Report?

Orchid Pharma Limited (ORCHPHARMA) Ratios

0 Followers

Orchid Pharma Limited Ratios

IN:ORCHPHARMA's free cash flow for Q1 2027 was ₹0.20. For the 2027 fiscal year, IN:ORCHPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.00 2.45 2.83 3.04 1.35
Quick Ratio
 0.00 1.53 1.68 2.03 0.73
Cash Ratio
 0.00 0.03 0.07 0.01 0.06
Solvency Ratio
 -0.04 0.09 0.32 0.33 0.19
Operating Cash Flow Ratio
 0.00 0.39 0.07 0.48 0.05
Short-Term Operating Cash Flow Coverage
 0.00 3.65 0.45 8.97 0.10
Net Current Asset Value
₹ 12.88B₹ 607.73M₹ 3.87B₹ 4.06B₹ -355.48M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.19 0.10 0.09 0.27
Debt-to-Equity Ratio
 0.00 0.28 0.14 0.12 0.48
Debt-to-Capital Ratio
 0.00 0.22 0.12 0.10 0.32
Long-Term Debt-to-Capital Ratio
 0.00 0.20 0.09 0.09 0.18
Financial Leverage Ratio
 0.00 1.48 1.33 1.33 1.78
Debt Service Coverage Ratio
 3.87 0.95 2.53 4.71 0.65
Interest Coverage Ratio
 3.40 0.43 5.58 4.64 0.90
Debt to Market Cap
 0.00 0.15 0.04 0.03 0.21
Interest Debt Per Share
 2.41 74.08 37.30 31.41 89.24
Net Debt to EBITDA
 0.00 8.65 1.06 0.93 2.16
Profitability Margins
Gross Profit Margin
25.73%19.54%38.48%16.62%10.62%
EBIT Margin
1.32%0.70%11.94%13.22%13.14%
EBITDA Margin
5.33%5.07%15.69%17.33%21.47%
Operating Profit Margin
4.42%0.70%8.80%9.49%4.46%
Pretax Profit Margin
1.23%2.51%10.79%10.87%8.30%
Net Profit Margin
0.92%2.53%10.81%11.25%6.96%
Continuous Operations Profit Margin
0.92%2.53%10.81%11.25%7.97%
Net Income Per EBT
74.74%100.94%100.19%103.50%83.84%
EBT Per EBIT
27.85%358.65%122.62%114.60%186.21%
Return on Assets (ROA)
0.00%1.08%5.90%5.93%3.78%
Return on Equity (ROE)
0.68%1.60%7.86%7.88%6.73%
Return on Capital Employed (ROCE)
0.00%0.35%5.78%6.01%3.48%
Return on Invested Capital (ROIC)
0.00%0.34%5.61%5.94%2.75%
Return on Tangible Assets
0.00%1.12%5.96%5.99%3.78%
Earnings Yield
0.17%0.84%2.51%1.72%2.96%
Efficiency Ratios
Receivables Turnover
 0.00 3.07 3.81 4.09 3.09
Payables Turnover
 0.00 2.84 2.55 2.97 3.41
Inventory Turnover
 0.00 2.55 1.74 2.58 2.60
Fixed Asset Turnover
 0.00 0.85 1.32 1.27 1.08
Asset Turnover
 0.00 0.42 0.55 0.53 0.54
Working Capital Turnover Ratio
 4.66 1.75 1.75 2.48 4.66
Cash Conversion Cycle
 0.00 133.53 162.85 107.80 151.38
Days of Sales Outstanding
 0.00 118.71 95.74 89.28 118.04
Days of Inventory Outstanding
 0.00 143.37 210.04 141.22 140.27
Days of Payables Outstanding
 0.00 128.55 142.93 122.70 106.93
Operating Cycle
 0.00 262.08 305.78 230.51 258.31
Cash Flow Ratios
Operating Cash Flow Per Share
 2.27 21.66 3.79 26.05 4.49
Free Cash Flow Per Share
 -29.03 -53.95 -25.81 12.65 -16.31
CapEx Per Share
 31.30 75.61 29.60 13.40 20.80
Free Cash Flow to Operating Cash Flow
 -12.79 -2.49 -6.81 0.49 -3.63
Dividend Paid and CapEx Coverage Ratio
 0.07 0.29 0.13 1.94 0.22
Capital Expenditure Coverage Ratio
 0.07 0.29 0.13 1.94 0.22
Operating Cash Flow Coverage Ratio
 0.00 0.30 0.11 0.93 0.06
Operating Cash Flow to Sales Ratio
 0.01 0.14 0.02 0.15 0.03
Free Cash Flow Yield
-2.95%-11.18%-3.30%1.14%-4.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 575.12 119.12 39.84 58.06 33.77
Price-to-Sales (P/S) Ratio
 5.29 3.02 4.31 6.53 2.35
Price-to-Book (P/B) Ratio
 3.87 1.90 3.13 4.58 2.27
Price-to-Free Cash Flow (P/FCF) Ratio
 -33.88 -8.94 -30.33 87.47 -23.50
Price-to-Operating Cash Flow Ratio
 433.37 22.27 206.64 42.47 85.30
Price-to-Earnings Growth (PEG) Ratio
 -6.40 -1.50 12.87 0.85 -0.01
Price-to-Fair Value
 3.87 1.90 3.13 4.58 2.27
Enterprise Value Multiple
 99.32 68.16 28.51 38.63 13.10
Enterprise Value
 49.88B 28.03B 41.24B 54.82B 18.73B
EV to EBITDA
 99.32 68.16 28.51 38.63 13.10
EV to Sales
 5.29 3.46 4.47 6.69 2.81
EV to Free Cash Flow
 -33.88 -10.24 -31.51 89.62 -28.13
EV to Operating Cash Flow
 433.37 25.51 214.63 43.51 102.14
Tangible Book Value Per Share
 253.91 239.31 246.52 238.71 168.62
Shareholders’ Equity Per Share
 253.91 253.84 249.88 241.80 168.72
Tax and Other Ratios
Effective Tax Rate
 0.25 >-0.01 >-0.01 -0.04 0.04
Revenue Per Share
 185.84 159.92 181.78 169.35 163.14
Net Income Per Share
 1.71 4.05 19.65 19.06 11.35
Tax Burden
 0.75 1.01 1.00 1.04 0.84
Interest Burden
 0.93 3.59 0.90 0.82 0.63
Research & Development to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
 0.10 0.19 0.10 0.01 0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.49 5.35 0.19 1.37 0.40
Currency in INR